Increasing trend of resistance to nalidixic acid and emerging ceftriaxone and ciprofloxacin resistance in Salmonella enterica serovar Typhimurium in Slovakia, 2005 to 2009

Juraj Majtan; Lubica Majtanova; Viktor Majtan

doi:10.1016/j.diagmicrobio.2010.04.009

Increasing trend of resistance to nalidixic acid and emerging ceftriaxone and ciprofloxacin resistance in Salmonella enterica serovar Typhimurium in Slovakia, 2005 to 2009

Diagn Microbiol Infect Dis. 2010 Sep;68(1):86-8. doi: 10.1016/j.diagmicrobio.2010.04.009.

Authors

Juraj Majtan¹, Lubica Majtanova, Viktor Majtan

Affiliation

¹ Institute of Zoology, Slovak Academy of Sciences, Bratislava, Slovakia. juraj.majtan@savba.sk

PMID: 20727477
DOI: 10.1016/j.diagmicrobio.2010.04.009

Abstract

A 5-year survey from 2005 to 2009 revealed an increasing trend of resistance to nalidixic acid (from 0% in 2005 to 11% in 2009) among 858 clinical isolates of Salmonella Typhimurium. In addition, 10 ceftriaxone-resistant and 3 ciprofloxacin-resistant Salmonella Typhimurium isolates were detected over the period of study.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / pharmacology*
Bacteriophage Typing
Ceftriaxone / pharmacology*
Ciprofloxacin / pharmacology*
Drug Resistance, Multiple, Bacterial*
Humans
Microbial Sensitivity Tests
Nalidixic Acid / pharmacology*
Salmonella Infections / epidemiology
Salmonella Infections / microbiology
Salmonella typhimurium / classification
Salmonella typhimurium / drug effects*
Salmonella typhimurium / virology
Slovakia / epidemiology

Substances

Anti-Bacterial Agents
Nalidixic Acid
Ciprofloxacin
Ceftriaxone